CPT1B and Insulin resistance: Using a skeletal muscle-specific CPT1b KO model, we showed that mitochondrial FAO inhibition results in a myriad of diabetes risk factors (reduced physical activity; increased circulating non-esterified fatty acids; and increased intramyocellular lipids, diacylglycerols, and ceramides) without inducing insulin resistance [14].